Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients

NCT00202540 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: S18986

Sponsor

Institut de Recherches Internationales Servier